Figure F-160 is titled “Rate of dry mouth for SSRIs compared with placebo.” The figure displays a forest plot reporting the risk difference of dry mouth stratified by paroxetine compared with placebo and sertraline compared with placebo. The forest plot depicts that a higher rate of dry mouth occurred among patients treated with paroxetine (1 trial, risk difference 0.10, 95% CI 0.04 to 0.16) and sertraline (5 trials, risk difference 0.03, 95% CI −0.01 to 0.07, I2 = 0.0%). Overall there was a 5% higher rate of dry mouth related to SSRIs than placebo (risk difference 0.05, 95% CI 0.02 to 0.09, I2 = 0.0%).

Figure F-160Rate of dry mouth for SSRIs compared with placebo

Timing of outcome assessment: 10 weeks (Panahi, 2001; Tucker, 2003; Zohar, 2002), 12 weeks (Davidson, 2006; Davidson, 2001; Brady, 2000).

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.